Market Place
Sourcing Support
Senti Bio Announces Q3 2024 Results & Recent Pipeline & Highlights
14 Nov 2024 //
GLOBENEWSWIRE
Senti Bio to Participate in Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Senti Bio Announces Q2 2024 Results And Pipeline Highlights
13 Aug 2024 //
GLOBENEWSWIRE
Senti Bio Executes CIRM Grant For SENTI-202 Clinical Development
05 Aug 2024 //
GLOBENEWSWIRE
Senti Bio Announces Reverse Stock Split
16 Jul 2024 //
GLOBENEWSWIRE
Senti Bio Receives CIRM Grant For CAR-NK Cell Therapy Development
01 Jul 2024 //
GLOBENEWSWIRE
Senti Bio Doses First Patient In SENTI-202 Trial For Hematologic Malignancies
13 May 2024 //
GLOBENEWSWIRE
Senti Bio Q1 2024 Results And Corporate Highlights
09 May 2024 //
GLOBENEWSWIRE
Senti Bio: Data Shows CAR-NK Potential For AML In SENTI-202 Preclinical
30 Apr 2024 //
GLOBENEWSWIRE
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results
21 Mar 2024 //
GLOBENEWSWIRE
Senti Bio Announces Steps to Prioritize Investment in Lead Clinical Program
05 Jan 2024 //
GLOBENEWSWIRE
Senti Bio Announces FDA Clearance of IND Application for SENTI-202
22 Dec 2023 //
GLOBENEWSWIRE
Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates
13 Nov 2023 //
GLOBENEWSWIRE
Senti Bio Announces New Strategic Collaboration with Celest Therapeutics
06 Nov 2023 //
GLOBENEWSWIRE
Senti Bio Announces Multiple Data Presentations at the Annual Meeting
31 Oct 2023 //
GLOBENEWSWIRE
Senti Bio Announces Multiple Data Presentations at the Cancer 2023 Meeting
27 Sep 2023 //
GLOBENEWSWIRE
Senti Bio to Participate in Upcoming Conferences
26 Sep 2023 //
GLOBENEWSWIRE
Senti Bio to Participate in Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates
11 Aug 2023 //
GLOBENEWSWIRE
Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities
10 Aug 2023 //
GLOBENEWSWIRE
Senti Bio offloads manufacturing site to Hong Kong PE firm for $38M
10 Aug 2023 //
ENDPTS
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at ASGCT
20 May 2023 //
GLOBENEWSWIRE
Senti Bio Announces First Quarter 2023 Results and Pipeline Updates
09 May 2023 //
GLOBENEWSWIRE
Senti Bio Announces Multiple Data Presentations at the ASGCT 2023 Annual Meeting
02 May 2023 //
GLOBENEWSWIRE
Senti Bio Highlights Preclinical Data Cell Therapy AACR Meeting
17 Apr 2023 //
GLOBENEWSWIRE
Senti Bio to Participate in Upcoming Investor Conferences
14 Apr 2023 //
GLOBENEWSWIRE
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results
22 Mar 2023 //
GLOBENEWSWIRE
Senti Bio Announces Presentations from CAR-NK Cell Oncology Pipeline
14 Mar 2023 //
GLOBENEWSWIRE
Senti Biosciences Announces New Employment Inducement Grants
03 Feb 2023 //
GLOBENEWSWIRE
Senti Bio to Present at the SVB Securities Global Biopharma Conference
01 Feb 2023 //
GLOBENEWSWIRE
Senti slams brakes on CAR-NK program to eke out remaining cash
27 Jan 2023 //
FIERCE BIOTECH
Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Therapies
27 Jan 2023 //
GLOBENEWSWIRE
Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
19 Dec 2022 //
GLOBENEWSWIRE
Senti Bio Highlights Data from Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH
11 Dec 2022 //
GLOBENEWSWIRE
Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH
23 Nov 2022 //
GLOBENEWSWIRE
Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH
03 Nov 2022 //
GLOBENEWSWIRE
Senti Bio Announces New Employment Inducement Grants
28 Oct 2022 //
GLOBENEWSWIRE
Senti Biosciences Spikes 28%
06 Oct 2022 //
NASDAQ
Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells
05 Oct 2022 //
GLOBENEWSWIRE
Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
20 Sep 2022 //
GLOBENEWSWIRE
Senti Bio to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 //
GLOBENEWSWIRE
Senti Biosciences Announces New Employment Inducement Grants
19 Aug 2022 //
GLOBENEWSWIRE
Senti Bio Reports Second Quarter Financial Results and Business Updates
15 Aug 2022 //
GLOBENEWSWIRE
Senti Bio Debuts as Publicly Traded Company Focused on Cell and Gene Therapies
09 Jun 2022 //
GLOBENEWSWIRE
Senti Bio Secures Additional Financing from Leaps by Bayer
24 May 2022 //
GLOBENEWSWIRE
Senti Bio Highlights Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells
18 May 2022 //
GLOBENEWSWIRE
Senti Bio to Present Data from Gene Circuit-Eng. Allogeneic CAR-NK Cell Therapy
02 May 2022 //
GLOBENEWSWIRE
Senti Bio to Present at Chardan`s GMCTM Summit
18 Apr 2022 //
GLOBENEWSWIRE
Senti Bio Presents New PC Data on Cancer-Killing Allogeneic CAR-NK Cells
08 Apr 2022 //
GLOBENEWSWIRE
Senti Bio to Present PC Data on Cancer-Killing Allogeneic CAR-NK Cells
08 Mar 2022 //
GLOBENEWSWIRE
Senti Bio, Sangamo alum Lee joins Lyell as CSO
01 Feb 2022 //
BIOCENTURY
Senti Bio to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference
06 Jan 2022 //
GLOBENEWSWIRE
Senti Bio &Dynamics Special Purpose Announce Business Combination Agreement
20 Dec 2021 //
GLOBENEWSWIRE
Senti to go public in $296M SPAC deal before hitting the clinic
20 Dec 2021 //
FIERCEBIOTECH
ASH: Senti Bio`s CAR-NK therapy shows promise in leukemia
09 Dec 2021 //
FIERCEBIOTECH
Senti Bio Highlights Colorectal Cancer Preclinical Data
12 Nov 2021 //
GLOBENEWSWIRE
Senti Bio to Present Preclinical Advances on SENTI-202 at ASH 2021
04 Nov 2021 //
GLOBENEWSWIRE
Senti Bio Invests in Cell Therapy Manufacturing Facility
23 Jun 2021 //
CONTRACTPHARMA
Senti Bio will build out its own San Francisco manufacturing facility
16 Jun 2021 //
ENDPTS
Senti Bio Signs Lease Agreement for Developing Allogeneic CAR-NK Cell Therapies
15 Jun 2021 //
GLOBENEWSWIRE
